1.High expression of the foot-and-mouth disease's structural protein P1 in Escherichia coli and analysis of its biology activity.
Xiao-Lan YU ; Shao-Bo XIAO ; Liu-Rong FANG ; Meng-Yu HU ; Lin YAN ; Xiao-Hui DONG ; Huan-Chun CHEN
Chinese Journal of Biotechnology 2005;21(1):163-166
Foot-and-mouth disease virus (FMDV) is the aetiological angent of a highly contagious viral disease. The complete gene encoding the structural protein of FMDV (P1) was subcloned into expression vector pGEX-KG, resulting in the fusion expression plasmid pKG-P1. After transformed into E. coli BL21(DE3) and induced by IPTG, the results of SDS-PAGE showed that the GST-P1 fusion protein was expressed in high level. The molecular weight of the fusion protein wa 110kD and the expressed products were soluble. Western-blotting was performed to confirm that the expressed fusion protein could specifically react with antiserum against FMDV. The fusion proteins were further purified by GST purification kit and an indirect ELISA (P1-ELISA) based on the purified proteins was developed. Comparison between P1-ELISA and the standard indirect haemagglutinin assay showed the two methods had 87 per cent agreement by detecting 864 serum samples, indicating the purified P1 protein was specific as the antigen of indirect P1-ELISA.
Capsid Proteins
;
biosynthesis
;
genetics
;
immunology
;
Escherichia coli
;
genetics
;
metabolism
;
Foot-and-Mouth Disease Virus
;
genetics
;
Recombinant Fusion Proteins
;
biosynthesis
;
genetics
;
immunology
2.Protective efficacy of recombinant rotavirus epitope-based vaccine in mice.
Xiao LIU ; Jia-qi LI ; Xin-yu XIONG ; Yu-na CHEN ; Mei PENG ; Qing DAI ; Yu-ling WEN ; Yuan-ding CHEN
Acta Academiae Medicinae Sinicae 2005;27(2):216-222
OBJECTIVETo evaluate in vivo immunological protective efficacy and safety of expressed recombinant rotavirus epitopes in mice.
METHODSUsing the Flock House virus capsid protein as a vector, three epitopes derived from rotavirus Vp4 amino acid 223-242 [rotavirus epitope A, (REA)], 243-262 [rotavirus epitope B, (REB)], and 234-251 [rotavirus epitope C, (REC)] were genetically engineered on the surface of the vector protein and expressed in pET-3 (E. coli BL21 [DE3]) system into multiple epitopes, REABC, which comprises REA, REB, and REC. Kunming strain mice were inoculated with the recombinant epitopes REABC, and then challenged perorally by cell culture-adapted rotavirus Wa (type G1P1A) and SA11 (type G3P2). Infection syndrome was observed, and virus antigen in stools of mice and serum neutralizing antibody activities were determined and analyzed.
RESULTSThe recombinant epitopes REABC significantly induced rotavirus specific neutralyzing antibodies against WA and SA11, reduced virus reproduction, elicitted immune memory in inoculated mice, and protected inoculated mice from challenge by WA or SA11 (P<0.001).
CONCLUSIONThe recombinant epitopes have high immunological protective efficacy and mild side effects in mice. It may be used as an epitope-based vaccine candidate in human.
Animals ; Antigens, Viral ; immunology ; Capsid ; immunology ; metabolism ; Capsid Proteins ; immunology ; Epitopes ; biosynthesis ; immunology ; Escherichia coli ; genetics ; Female ; Genetic Vectors ; Male ; Mice ; Random Allocation ; Recombinant Proteins ; biosynthesis ; immunology ; Rotavirus ; immunology ; Rotavirus Infections ; immunology ; prevention & control ; Viral Vaccines ; immunology
3.Construction and eukaryotic expression of PVAX1-hPV58mE6E7fcGB composite gene vaccine.
Journal of Biomedical Engineering 2013;30(5):1102-1107
To construct and express a composite gene vaccine for human papillomavirus 58(HPV58)-associated cervical cancer, we inserted HPV58mE6E7 fusion gene into pCI-Fc-GPI eukaryotic expression vector, constructing a recombinant plasmid named pCI-sig-HPV58mE6E7-Fc-GPI. Then we further inserted fragment of sig-HPV58mE6E7Fc-GPI into the novel vaccine vector PVAX1-IRES-GM/B7, constructing PVAX1-HPV58mE6E7FcGB composite gene vaccine. PVAX1-HPV58mE6E7FcGB vaccine was successfully constructed and identified by restriction endonuclease and sequencing analysis. Eukaryotic expression of fusion antigen sig-HPV58mE6E7-Fc-GPI and molecular ad-juvant GM-CSF and B7. 1 were proved to be realized at the same time by flow cytometry and immunofluorescence. So PVAX1-HPV58mE6E7FcGB can be taken as a candidate of therapeutic vaccine for HPV58-associated tumors and their precancerous transformations.
Cancer Vaccines
;
biosynthesis
;
genetics
;
Capsid Proteins
;
biosynthesis
;
genetics
;
Female
;
Humans
;
Oncogene Proteins, Viral
;
biosynthesis
;
genetics
;
Papillomavirus E7 Proteins
;
biosynthesis
;
genetics
;
Papillomavirus Vaccines
;
biosynthesis
;
Recombinant Proteins
;
biosynthesis
;
genetics
;
immunology
;
Uterine Cervical Neoplasms
;
prevention & control
;
Vaccines, DNA
;
biosynthesis
4.Expression, purification and immunogenicity analysis of HPV type 18 virus-like particles from Escherichia coli.
Minghui XIE ; Shaowei LI ; Wentong SHEN ; Zhongyi LI ; Yudi ZHUANG ; Xiaobing MO ; Ying GU ; Ting WU ; Jun ZHANG ; Ningshao XIA
Chinese Journal of Biotechnology 2009;25(7):1082-1087
Here, we presented a method to bacterially express the major structural protein L1 of Human Papillomavirus type 18 (HPV18) as soluble form. We found that the purified L1 could self-assemble to virus-like particles (VLPs). Further, we investigated the immunogenicity and the induced level of neutralizing antibody using these VLPs. First, the genome of HPV18 was cloned from a patient in Xiamen. It was used as template for PCR amplification of HPV18 L1 gene. The resultant DNA fragment was inserted into expression vector pTrxFus and expressed in Escherichia coli GI724. Second, L1 protein was purified by ammonium sulfate precipitation, ion-exchange chromatography and hydrophobic interaction chromatography; and the purified L1 was subjected to self-assembly to form VLPs with the removal of premixed reductant DTT. Finally, the size and morphology of these VLPs was investigated by Dynamic Light Scattering and Transmission Electronic Microscopy as 29.34 nm in hydrated radius and globular particles similar with native HPV18. The half effective dosage (ED50) and maximum level of neutralizing antibody elicitation were measured by vaccinations on mice, rabbit and goat using pseudovirus neutralization cell model. The results showed that the ED50 of HPV18 VLPs is 0.006 microg in mice, and the maximum titer of neutralizing antibody elicited in rabbit and goat is up to 10(7). As a conclusion, we can provide HPV18 VLPs with highly immunogenicity from prokaryote expression system, which may pave a new way for research and development of prophylactic vaccine for HPV18.
Animals
;
Capsid Proteins
;
biosynthesis
;
genetics
;
immunology
;
Escherichia coli
;
genetics
;
metabolism
;
Goats
;
Human papillomavirus 18
;
immunology
;
isolation & purification
;
Mice
;
Oncogene Proteins, Viral
;
biosynthesis
;
genetics
;
immunology
;
Rabbits
;
Recombinant Proteins
;
biosynthesis
;
genetics
;
immunology
;
Virion
;
genetics
;
immunology
5.Construction and eukaryotic expression of recombinant plasmid encoding fusion protein of goat complement C3d and foot-and-mouth disease virus VP1.
Jieyu LING ; Zhao LIU ; Tiezhu TONG ; Huiying FAN ; Dekun ZHANG ; Huanchun CHEN ; Aizhen GUO
Chinese Journal of Biotechnology 2008;24(2):209-213
We constructed a recombinant plasmid encoding VP1 gene of O type foot-and-mouth disease virus fused to a molecular adjuvant, goat complement C3d gene. The goat C3d gene was cloned and three copies were tandem-linked with the linker (G4S)2 sequence. VP1 gene of O type foot-and-mouth disease virus was linked to three tandem repeats of C3d through the linker sequence and cloned into pUC19 to obtain the recombinant plasmid pUC19-VP1-C3d3. The VP1-C3d3 fusion gene was then subcloned into the eukaryotic vector pcDNA3.1(+) that had been modified to contain the tissue plasminogen activator (tPA) leader sequence to obtain pcDNA3.1-tPA-VP1-C3d3. HeLa cells were transfected with pcDNA3.1-tPA-VP1-C3d3 by Lipofectamine 2000. Indirect immunofluorescent assay and Western blot assay showed that VP1-C3d3 fusion gene was successfully expressed in HeLa cells. The fusion protein with the expected size 133 kD could be secreted outside the cells. This study laid a good foundation to further research on the novel vaccine against foot-and-mouth disease virus by using goat C3d as a molecular adjuvant to enhance the immunogenicity of VP1.
Animals
;
Capsid Proteins
;
biosynthesis
;
genetics
;
Cloning, Molecular
;
Complement C3d
;
biosynthesis
;
genetics
;
immunology
;
Female
;
Foot-and-Mouth Disease Virus
;
genetics
;
Goats
;
HeLa Cells
;
Humans
;
Immunologic Factors
;
biosynthesis
;
genetics
;
immunology
;
Plasmids
;
genetics
;
Recombinant Fusion Proteins
;
biosynthesis
;
genetics
;
immunology
;
Transfection
6.Construction and immunogenicity analysis of recombinant replication-defective human adenovirus type 5 bearing the porcine circovirus type 2 Cap protein gene.
Ting GONG ; Shou-Feng ZHANG ; Ye LIU ; Cheng-Long SUN ; Yang YANG ; Qi CHEN ; Fang QIAN ; Bo-Hao LIU ; Rong-Liang HU
Chinese Journal of Virology 2013;29(1):26-31
To construct a recombinant replication-defective human adenovirus type 5 expressing Cap protein of PCV2 and test the immunological efficacy in mice. In this study, the recombinant replication-defective human adenovirus type 5, named as rAd5-Cap (wt-rAd5), was constructed through homologous recombination internally in the HEK293AD cells after co-transfection of the Pac I-linearized backbone plasmid and the shuttle plasmid pacAd5CMV-Cap containing the open reading frame (ORF2) of the porcine circovirus type 2 (PCV2) cap protein or pacAd5CMV without inserted fragment. Furthermore, the rAd5-Cap could induce the expression of PCV2 cap protein in the HEK293AD cells with high efficacy evaluated by the RT-PCR and indirect immunofluorescence assay (IFA). The virus titer of rAd5-Cap could reach up to 10(8.5) TCID50/mL similarly to that of wt-rAd5, indicating that there was little affect on the virus proliferation after the insertion of PCV2 cap protein gene. The humeral immune responses could be activated and detected 14 days after the inoculation of the mice with 10(7) TCID50 rAd5-Cap intramuscularly, and constantly in crease in another 14 days. These molecular biological and animal experiments results demonstrated that the PCV2 cap protein could be efficiently expressed by the recombinant adenovirus rAd5-Cap in eukaryotic cells and induce robust immune responses in mice, which laid a good foundation for the development of new type vaccine against porcine circovirus.
Adenoviruses, Human
;
genetics
;
Animals
;
Antibodies, Viral
;
blood
;
Capsid Proteins
;
genetics
;
immunology
;
Circovirus
;
immunology
;
Defective Viruses
;
genetics
;
HEK293 Cells
;
Humans
;
Mice
;
Recombinant Proteins
;
biosynthesis
;
immunology
;
Virus Replication
7.Preparation and characterization of specific monoclonal antibodies against hexon of HAdV 3.
Rong ZHOU ; Hui-Ying SHENG ; Xin-Gui TIAN ; Chang-Bing WANG ; Si-Tang GONG ; Qiao-Lian CHEN
Journal of Southern Medical University 2008;28(6):1008-1010
OBJECTIVETo obtain the monoclonal antibody against hexon protein of human adenovirus.
METHODSBALB/c mice were immunized with purified recombinant hexon protein, and the spleen cells of the mice were isolated and fused with myloma cells. Four hybridoma cell strains were screened by indirect ELISA and cultured, and the sensitivity, specificity and virus neutralizing activity were analyzed with ELISA, Western blotting and neutralizing test.
RESULTSThe mouse ascites produced by these hybridoma cells contained specific monoclonal antibodies against hexon protein of human adenovirus as identified by ELISA and Western blot, and the antibody generated by 4C6 strain showed human adenovirus type 3-neutralizing activity.
CONCLUSIONThe monoclonal antibodies against hexon protein with high specificity have been successfully obtained, and these antibodies can be useful in developing assays for early diagnosis of HAdV3 infection and also in study of therapeutic drugs of the infection.
Adenoviruses, Human ; chemistry ; immunology ; Animals ; Antibodies, Monoclonal ; biosynthesis ; immunology ; Antibodies, Viral ; biosynthesis ; immunology ; Blotting, Western ; Capsid Proteins ; biosynthesis ; genetics ; immunology ; Enzyme-Linked Immunosorbent Assay ; Escherichia coli ; genetics ; Humans ; Hybridomas ; secretion ; Mice ; Mice, Inbred BALB C ; Recombinant Proteins ; biosynthesis ; immunology
8.Study on genetic transformation of antigen G3VP7 gene of human rotavirus in peanut.
Yuchen JIA ; Kai ZHAO ; Xin XUE ; Wei LI ; Shaowei LI ; Dehu LIU
Journal of Biomedical Engineering 2012;29(2):328-331
In order to increase the expression level of target gene and to simplify the purifying process of separation and purification, we performed the transgenetic research of antigen VP7 gene into peanut via Agrobacterium tumefaciens. The plant binary expression vector is pBOG3VP7 harboring fusion gene oleosin-vp7, which is promoted by ole-promoter. Cotyledon nodes were used as transformation recipients. Transformed individuals were obtained through selection on medium containing 125 mg L-1 Kan. Integration of transgenes was assessed by PCR amplification and PCR-Southern blot hybridization. Taking pBOG3VP7 plasmid as positive control, non-transformed peanut as negative control. 6 plants among 11 plants grown up through seletion medium were detected by PCR and the rate of positive plants is 54.5%. PCR positive plants were further analysed by PCR-Southern blot hybridization. The results showed that 3 plants have DNA bloting bands. The results also showed that the foreign gene was integrated into genome of transformed peanuts. Elevated expression of rotavirus VP7 antigen in transgenic peanuts was a critical factor in the development of efficient and cheap plant oral vaccine.
Agrobacterium tumefaciens
;
genetics
;
Antigens, Viral
;
biosynthesis
;
genetics
;
Arachis
;
genetics
;
metabolism
;
Capsid Proteins
;
biosynthesis
;
genetics
;
Plants, Genetically Modified
;
genetics
;
metabolism
;
Rotavirus
;
genetics
;
immunology
;
Transformation, Genetic
;
Vaccines, Synthetic
9.Gene cloning and immunogenicity analysis of the structural proteins VP1-VP4 of enterovirus 71.
Yuan-bin SONG ; Nan YU ; Si-jie HE ; Xin-xin CHEN ; Bin WANG ; Xiao-yan CHE ; Qi-yi ZENG
Journal of Southern Medical University 2011;31(11):1846-1850
OBJECTIVETo clone the genes encoding the structural proteins VP1-VP4 of enterovirus 71 and investigate the immunogenicity of the expressed recombinant proteins.
METHODSThe VP1-VP4 cDNAs were amplified by RT-PCR from the extracted viral RNA and cloned into pMD19-T vector. The cloned VP1-VP4 genes were then inserted into the multi-cloning sites of plasmid pQE30a and expressed in E. coli M15 with IPTG induction. After washing with 8 mol/L urea and purification with Ni-affinity chromatography, the recombinant proteins obtained were tested for immunogenicity by Western blotting and ELISA using rabbit antisera against enterovirus 71 and Coxsackie Virus A16.
RESULTSThe recombinant VP1-VP4 proteins were highly expressed in E. coli M15 and the purified proteins could be specifically recognized by the rabbit sera against enterovirus 71.
CONCLUSIONThe expressed enterovirus 71 structural proteins show good immunogenicity and can be used for developing enterovirus 71 vaccine and detection kits.
Animals ; Capsid Proteins ; biosynthesis ; genetics ; immunology ; Cloning, Molecular ; Enterovirus A, Human ; genetics ; immunology ; Enterovirus Infections ; virology ; Escherichia coli ; genetics ; metabolism ; Humans ; Immunogenetic Phenomena ; Mice ; Rabbits ; Recombinant Proteins ; biosynthesis ; genetics ; immunology
10.Construction and immunogenicity of recombinant porcine parvovirus-like particles with somatostatin.
Xuehua ZHANG ; Qisheng ZHENG ; Jin CHEN ; Gang XUE ; Hongyan HOU ; Jibo HOU
Chinese Journal of Biotechnology 2010;26(8):1057-1067
In order to obtain a virus-like particle vaccine both for porcine parvovirus (PPV) prevention and growth-promotion, VP2 gene of PPV NJ-a strain was amplified with PCR, and four copies of synthetic somatostatin gene were fused to the N-terminal of VP2 gene. The fused gene was cloned into pFast-HT A to construct the recombinant plasmid pFast-SS4-VP2, then the pFast-SS4-VP2 was transformed into DH10Bac competent cells and recombined with shuttle vector Bacmid, followed by identification with blue-white screening and PCR analysis for three cycles, and the positive recombinant was named as rBacmid-SS4-VP2. The positive Sf-9 cells were transfected with rBacmid-SS4-VP2 by Lipofectamine to produce recombinant baculovirus. When the cytopathic effect (CPE) was obvious, the transfected Sf-9 cell was harvested, and the positive recombinant virus was named as rBac-SS4-VP2. The insertion for the target gene into baculovirus genome was confirmed with PCR. SDS-PAGE and Western blotting revealed that the calculated protein of approximately 68 kDa was in the expressed in the insect cells. The Sf-9 cells infected with rBac-SS4-VP2 were stained positive against PPV antibody using the indirect immunofluorescence assay (IFA). Moreover, the virus particle self-assembly was observed under electron microscopy. 90 four-week-old mice were immunized by the recombinant protein coupled with different adjuvants alhydrogel, IMS and oil. VP2-specific ELISA antibodies, PPV-specific neutralizing antibody, somatostatin antibody and growth hormone levels were examined to evaluate the immunogenicity of this virus like particle. Results indicated that mice groups immunized rSS4-VP2 protein with alhydrogel and IMS developed similar humoral immune response comparing with inactived PPV vaccine. Mice group immunized with rSS4-VP2 generated higher level of SS antibody and growth hormone comparing with negative control, mice receiving rSS4-VP2 with alhydrogel developed the highest antibody titre than all other groups, while the oil group developed the lowest antibody level. This study provides not only a new rout for production of safe and effective virus like particle subunit vaccine, but also the foundations for peptide presentation and multivalent subunit vaccine design.
Animals
;
Antigens, Viral
;
biosynthesis
;
genetics
;
Artificial Gene Fusion
;
Baculoviridae
;
genetics
;
Capsid Proteins
;
biosynthesis
;
genetics
;
Mice
;
Parvoviridae Infections
;
prevention & control
;
Parvovirus, Porcine
;
genetics
;
immunology
;
Recombinant Proteins
;
biosynthesis
;
genetics
;
immunology
;
Somatostatin
;
genetics
;
Swine
;
Vaccines, Virus-Like Particle
;
biosynthesis
;
immunology
;
Viral Vaccines
;
biosynthesis
;
immunology
;
Virion
;
genetics
;
immunology